Skip to main content
. 2019 Jul 25;15(2):148–156. doi: 10.1159/000501473

Fig. 2.

Fig. 2

Duration of tamoxifen exposure during pregnancy. Pregnancies without malformations are depicted in green; pregnancies complicated by major malformations are depicted in red; pregnancies with minor malformations are depicted in orange. The letter by Clark [46] and the AstraZeneca Safety Database analysis [8] are not presented in this graph, as the exact duration of tamoxifen exposure was not specified.